In particular, engagement with integrins, namely β1-(ITGB1) or β3-integrin (ITGB3), has been shown to enhance IGF-1R signaling in cancer cell models, fibroblasts, and endothelial cells (28, 29, 30, 31). The gene discussed is ITGB3; the disease is cancer.